In the central nervoussystem, some specific phosphodiesterase(PDE) isoforms modulate pathways involved in neuronal plasticity.Accumulating evidence suggests that PDE9 may be a promising therapeutictarget for neurodegenerative diseases. This evidence concerns the gene ALDH7A1 and neurodegenerative disease.